[go: up one dir, main page]

CO5271679A1 - Inhibidores de proteasa 7-14 miembros - Google Patents

Inhibidores de proteasa 7-14 miembros

Info

Publication number
CO5271679A1
CO5271679A1 CO00011383A CO00011383A CO5271679A1 CO 5271679 A1 CO5271679 A1 CO 5271679A1 CO 00011383 A CO00011383 A CO 00011383A CO 00011383 A CO00011383 A CO 00011383A CO 5271679 A1 CO5271679 A1 CO 5271679A1
Authority
CO
Colombia
Prior art keywords
alkyl
het
group
nr2h
cycloalkyl
Prior art date
Application number
CO00011383A
Other languages
English (en)
Inventor
Marquis Robert Wells Jr
Daniel Frank Veber
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5271679A1 publication Critical patent/CO5271679A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16—Eight-membered rings
    • C07D313/18—Eight-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)

Abstract

Un compuesto de Fórmula I:<EMI FILE="00011383_1" ID="1" IMF=JPEG >en la que: A es C(O) o CH(OH); R1 es <EMI FILE="00011383_2" ID="2" IMF=JPEG >R´ es seleccionado del grupo que consiste en H, alquilo C1-6, Ar-alquilo C0-6 o Het alquilo C0-6; R" es seleccionado del grupo que consiste en H, alquilo C1-6, Ar-alquilo C0-6 o Het alquilo C0-6; R"AND#39 es seleccionado del grupo que consiste en H, alquilo C1-6, cicloalquilo C3-6-alquilo C0-6, Ar-alquilo C0-6 o Het-alquilo C0-6; R2 es seleccionado del grupo que consiste en H, alquenilo C2-6, alquinilo C2-6, Het. Ar o alquilo C1-6 opcionalmente sustituido con 0R6, SR6, NR62, R6NC(O)OR5, CO2R6, CO2NR62, N(C=NH)NH2, Het o Ar; R3 es seleccionado del grupo que consiste en H, alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6, Het-alquilo C0-6, R4C(O)-, R4C(S)-, R4SO2-, R4OC(O)-, R4R7NC(O)-, R4R7NC(S)-, R7HNCH(R7)C(O)-, o R4OC(O)NR7CH(R7)C(O)-; R4 es seleccionado del grupo que consiste en alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6 o Het-alquilo C0-6; R5 es seleccionado del grupo que consiste en H, alquilo C1-6, Ar-alquilo C0-6 o Het-alquilo C0-6;R6 y R7 son seleccionados del grupo que consiste en H, alquilo C1-6, Ar-alquilo C0-6 o Het-alquilo C0-6;M es seleccionado del grupo que consiste en: HC = CH, H2C-CH2, H(OR2)C-C(OR2)H, H(OR2)C-CH2, H(NR2H)C-C(NR2H)H, o H(OR2)C-C(NR2H)H, o H(NR2H)C-CH2; n es 1-7; L es 0-1;o sales, hidratos y solvatos farmacéuticamente aceptables de los mismos.
CO00011383A 1999-02-19 2000-02-18 Inhibidores de proteasa 7-14 miembros CO5271679A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12069999P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
CO5271679A1 true CO5271679A1 (es) 2003-04-30

Family

ID=22392011

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00011383A CO5271679A1 (es) 1999-02-19 2000-02-18 Inhibidores de proteasa 7-14 miembros

Country Status (8)

Country Link
EP (1) EP1153022A4 (es)
JP (1) JP2002537297A (es)
AU (1) AU3235100A (es)
CO (1) CO5271679A1 (es)
DZ (1) DZ3083A1 (es)
HK (1) HK1042695A1 (es)
PE (1) PE20001486A1 (es)
WO (1) WO2000049011A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
AU1474801A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
EP1232154A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
EA005893B1 (ru) 2000-03-21 2005-06-30 Смитклайн Бичам Корпорейшн Ингибиторы протеаз
IL155961A0 (en) * 2000-11-17 2003-12-23 Medivir Uk Ltd Cysteine protease inhibitors
WO2002088106A2 (en) * 2000-11-17 2002-11-07 Medivir Ab Cysteine protease inhibitors
EP1482019B1 (de) 2003-05-27 2006-09-27 MERCK PATENT GmbH Pyranderivate
DE502004001386D1 (de) * 2003-05-27 2006-10-19 Merck Patent Gmbh Pyranderivative mit exocyclischer Doppelbindung
EP1757284A1 (en) * 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
AU6252794A (en) * 1993-03-03 1994-09-26 Eli Lilly And Company Balanoids
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios

Also Published As

Publication number Publication date
DZ3083A1 (fr) 2004-06-02
AU3235100A (en) 2000-09-04
EP1153022A1 (en) 2001-11-14
HK1042695A1 (zh) 2002-08-23
WO2000049011A1 (en) 2000-08-24
PE20001486A1 (es) 2001-02-08
JP2002537297A (ja) 2002-11-05
EP1153022A4 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
CO5200785A1 (es) Uso terapeutico de quinazolina
AR240929A2 (es) &#34;n-piridinsulfonil-n&#39;-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas&#34;
CO5310534A1 (es) Nuevos derivados de androstano anti-inflamatorios
DE59308619D1 (de) Germicide wirkstoffkombinationen
CO5261616A1 (es) Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
RU2009102832A (ru) С-фенил-1-тилоглюцитолы
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
DE69716292D1 (de) Benzopyranderivate
CO5251427A1 (es) Oxazolidinonas que tienen la fucion de sulfoximina
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
CO5080791A1 (es) Derivados de la piperidina que tienen efectos sobre sistemas con serotonina
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
CO5261527A1 (es) Eteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
CO5261538A1 (es) Nuevos acidos (aminopropil) metilfosfinicos
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
ATE302776T1 (de) Kondensierte pyridoindolderivate
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DE60121048D1 (de) PYRAZINOi1&#39;2&#39;:1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
CO5180536A1 (es) Inhibidores de proteasas catepsina

Legal Events

Date Code Title Description
FC Application refused